Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ore Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (7)	3/15/2008 2:23:17 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 50

WHEREAS, following the sale of the Company's Genomics Division, Miller and the Board were unable to reach agreement on the future direction of the Company That seems unlikely--I wonder why they put that in there? Even the casual observer like myself has a pretty good feeling for why genomics was a bust. I have a guess: The DR was a bust and Miller knows that and he got out. Time will tell, but right now my $1.45 shares are trading for 50 cents, I guess I'd rather have 70 cents--makes you wonder if we are ever likely to see more than that price again. Why sell out for 70 cents if more is possible?